Sorry, you need to enable JavaScript to visit this website.

Branded vs. Generic

  • Branded drugs are more expensive because they’re newer, generally groundbreaking, and often for conditions that are difficult to treat. However, after a certain period of time, these same innovative medicines become generic medicines.

  • The difference between our approach and that of many other companies is that when a medicine becomes a generic, we still assume responsibility. Rather than focus on just what’s in development, we continue to closely monitor the quality, safety, and reliability of our generic medicines.

Related Articles

Science & Innovation

Behind the Science: A New Path to Tackling Metastatic Breast Cancer

In recent decades, advances in breast cancer treatment have helped to improve health outcomes for many patients, but scientists remain vigilant in their quest to further reduce both the incidence and impact of the disease.

Jennifer, Pfizer thumbnail

Purpose & Ideals

Hiding in Plain Sight: The Racial Toll of Lyme Disease

Lyme disease is the most common vector-borne illness in the United States. New research indicates that people of color are more likely to develop more severe Lyme disease.

Friends walking in forest thumbnail

Science & Innovation

Behind the Science: Breaking the Cycle of C. difficile

The human gut contains a variety of bacteria and other microorganisms comprising the microbiome, and that’s a good thing! Clostridioides difficile, also known as C. difficile, is one such bacterium.

Two men conversing thumbnail, Pearl River

How Drugs Are Made

The medicines available today have taken an average of 12 years to develop. With dedication, creativity, and science, we can significantly cut that time.

Clinical Trials

Learn more about the process of joining a clinical trial and find a trial near you.

Go to Pfizer Clinical Trials Site Details